- Report
- March 2022
- 198 Pages
Global
From €3955EUR$4,450USD£3,426GBP
- Report
- November 2022
- 160 Pages
Global
€3022EUR$3,400USD£2,618GBP
- Report
- January 2024
- 199 Pages
Global
From €3955EUR$4,450USD£3,426GBP
- Report
- January 2023
- 156 Pages
Europe
From €3066EUR$3,450USD£2,656GBP
- Report
- January 2023
- 132 Pages
From €3066EUR$3,450USD£2,656GBP
- Report
- January 2023
- 127 Pages
North America
From €3066EUR$3,450USD£2,656GBP
- Report
- January 2023
- 166 Pages
Asia Pacific
From €3066EUR$3,450USD£2,656GBP
- Report
- January 2023
- 135 Pages
Middle East, Africa
From €3066EUR$3,450USD£2,656GBP
- Report
- October 2022
- 209 Pages
Global
From €3955EUR$4,450USD£3,426GBP
- Report
- August 2022
- 104 Pages
From €3066EUR$3,450USD£2,656GBP
- Report
- October 2023
- 38 Pages
Global
From €3551EUR$3,995USD£3,076GBP
- Report
- December 2019
- 104 Pages
Asia Pacific
From €7995EUR$8,995USD£6,926GBP
- Report
- January 2025
- 230 Pages
United States
From €3111EUR$3,500USD£2,695GBP
- Report
- October 2024
- 80 Pages
Vietnam
From €3200EUR$3,600USD£2,772GBP
- Report
- July 2024
- 187 Pages
China
From €1600EUR$1,800USD£1,386GBP
- Report
- July 2024
- 326 Pages
China
From €3555EUR$4,000USD£3,080GBP
- Report
- January 2024
- 310 Pages
Global
From €3111EUR$3,500USD£2,695GBP
- Report
- November 2023
- 29 Pages
United States
€2222EUR$2,500USD£1,925GBP
- Report
- September 2023
- 101 Pages
North America
From €2622EUR$2,950USD£2,271GBP
- Report
- September 2023
- 87 Pages
Middle East, Africa
From €2622EUR$2,950USD£2,271GBP

The Flu Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Flu Vaccines are specifically designed to protect against influenza, a highly contagious virus that can cause severe illness and even death. Flu Vaccines are typically administered annually, and are recommended for people of all ages, including pregnant women and those with chronic health conditions.
Flu Vaccines are typically developed by pharmaceutical companies, and are then approved and distributed by government health agencies. In addition to traditional flu vaccines, there are also recombinant vaccines, which are produced using genetic engineering techniques.
Companies in the Flu Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more